COVID-19 Outbreak Information –

Daniel Lasanow

Director Global Operations and Member of the Executive Committee of PolyPeptide Group

Daniel Lasanow, Director Global Operations and Member of the Executive Committee of PolyPeptide Group, is a Belgian citizen born in 1962. Mr. Lasanow joined the company as Director Global Operations of Polypeptide Laboratories (Sweden) AB in 2016 from Siegfried Pharma, where he served as Senior Vice President, Multi-sites Managing Director. Prior to that, Mr. Lasanow served as Multi-sites Managing Director (2012 – 2015) and as Multi-sites Production & Technologies Director (2011 – 2012) at BASF Pharma, which later became part of Siegfried Pharma. Between 2009 and 2011, he served as Production Director, Belgium at NextPharma Technologies. Beginning in 2000, Mr. Lasanow was Production Director, Belgium at Lonza and UCB Bioproducts (which was later acquired by Lonza). He started his career in 1992 at GSK Pharmaceutical. Mr. Lasanow holds a Master of Sciences in Organic Chemistry from the University of Louvain, Belgium.